Biocrossroads Studies Archives - The Central Indiana Corporate Partnership

Indiana Life Sciences Capital: A summary of 2023 investments

Raquel Bahamonde2024-05-08T11:39:26-04:00May 6, 2024|

A Strategic Roadmap for Advancing Indiana’s Life Sciences Industries

Raquel Bahamonde2024-01-09T00:23:58-05:00January 8, 2024|

Indiana Life Sciences Capital: A summary of 2022 investments

Raquel Bahamonde2024-01-30T09:09:48-05:00April 17, 2023|

Recruiting and retaining talent who make life-saving medicine: State of the Pharmaceutical Manufacturing Workforce in Indiana

Raquel Bahamonde2023-03-09T09:56:05-05:00March 9, 2023|

BioCrossroads 2022 Annual Report

Raquel Bahamonde2023-03-09T09:47:28-05:00March 2, 2023|

BioCrossroads and the Indiana Life Sciences Ecosystem: Tracking Two Decades of Progress and Charting a Path for Sustained Success

Raquel Bahamonde2022-11-14T10:15:48-05:00October 6, 2022|

ESSENTIAL: The impact of healthcare and life sciences sector in Indiana

Raquel Bahamonde2022-06-15T12:45:29-04:00June 15, 2022|

Indiana Life Sciences Capital: A Summary of 2021 Investments

Raquel Bahamonde2022-04-19T09:12:41-04:00April 19, 2022|

BioCrossroads 2021 Annual Report

Raquel Bahamonde2022-03-28T09:42:52-04:00March 28, 2022|

Supporting Life Sciences: A look back at BioCrossroads’ capital strategy

Raquel Bahamonde2022-07-29T14:41:04-04:00October 27, 2021|